SAPIR v. AVERBACK

Civil Action No. 14-7331 (JLL) (JAD).

ROY SAPIR, on behalf of himself and all other similarly situated, Plaintiff, v. PAUL AVERBACK and NYMOX PHARMACEUTICAL CORPORATION, Defendants.

United States District Court, D. New Jersey.

February 10, 2016.


Attorney(s) appearing for the Case

Gil Rodriguez, Movant, represented by LAURENCE M. ROSEN , THE ROSEN LAW FIRM, PA.

Charles Tuskes, Movant, represented by EDUARD KORSINSKY , LEVI & KORSINSKY LLP.

The Nymox Investor Group, Movant, represented by JAMES E. CECCHI , CARELLA BYRNE CECCHI OLSTEIN BRODY & AGNELLO, P.C..

Norman Jacobs, Movant, represented by GARY S. GRAIFMAN , KANTROWITZ, GOLDHAMER & GRAIFMAN, ESQS..

Harry Lattanzio, Lead Plaintiff, represented by JAMES E. CECCHI , CARELLA BYRNE CECCHI OLSTEIN BRODY & AGNELLO, P.C..

Andrew Silverman, Lead Plaintiff, represented by JAMES E. CECCHI , CARELLA BYRNE CECCHI OLSTEIN BRODY & AGNELLO, P.C..

Rock 49th Restaurant Group, Lead Plaintiff, represented by JAMES E. CECCHI , CARELLA BYRNE CECCHI OLSTEIN BRODY & AGNELLO, P.C..

PRS, Inc., Lead Plaintiff, represented by JAMES E. CECCHI , CARELLA BYRNE CECCHI OLSTEIN BRODY & AGNELLO, P.C..

Network Accreditation Services, Inc., Lead Plaintiff, represented by JAMES E. CECCHI , CARELLA BYRNE CECCHI OLSTEIN BRODY & AGNELLO, P.C..

ROY SAPIR, Plaintiff, represented by GARY S. GRAIFMAN , KANTROWITZ, GOLDHAMER & GRAIFMAN, ESQS. & TINA MOUKOULIS , LAW OFFICE OF BERNARD M. GROSS, PC.

PAUL AVERBACK, Defendant, represented by ANDREW B. JOSEPH , DRINKER, BIDDLE & REATH, LLP, STEPHEN G. STROUP , DRINKER BIDDLE & REALTH LLP & JOSHUA M. LINK , DRINKER BIDDLE & REATH LLP.

NYMOX PHARMACEUTICAL CORPORATION, Defendant, represented by ANDREW B. JOSEPH , DRINKER, BIDDLE & REATH, LLP, STEPHEN G. STROUP , DRINKER BIDDLE & REALTH LLP & JOSHUA M. LINK , DRINKER BIDDLE & REATH LLP.


OPINION

This matter comes before the Court by way of the Motion to Dismiss the Amended Class Action Complaint (the "Amended Complaint" or "AC") filed by Defendants Paul Averback ("Averback") and Nyrnox Pharmaceutical Corporation ("Nyrnox" or "the Company'') (collectively, "Defendants"). (ECF No. 32.) In...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases